Adam's Legal Newsletter β’ 918 implied HN points β’ 17 Aug 23
- The Fifth Circuit's opinion on standing related to mifepristone is controversial and may be overturned.
- Plaintiffs in the case lack standing as their claims are speculative and not aligned with the interests of their potential patients.
- The court's reasoning may have far-reaching implications, allowing doctors to challenge a wide range of government regulations based on personal aesthetic preferences.